Your browser doesn't support javascript.
loading
Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study Group.
Chiwata, Masahiko; Itonaga, Hidehiro; Sato, Shinya; Hashimoto, Miki; Fujioka, Machiko; Kasai, Sachie; Sakamoto, Hikaru; Toriyama, Eo; Nakashima, Jun; Kamijo, Rena; Kitanosono, Hideaki; Kobayashi, Yuji; Horai, Makiko; Taguchi, Masataka; Matsuo, Masatoshi; Makiyama, Junya; Takasaki, Yumi; Matsuo, Emi; Horio, Kensuke; Ando, Koji; Sawayama, Yasushi; Taguchi, Jun; Kawaguchi, Yasuhisa; Tsushima, Hideki; Imanishi, Daisuke; Imaizumi, Yoshitaka; Yoshida, Shinichiro; Jo, Tatsuro; Nonaka, Hiroaki; Moriuchi, Yukiyoshi; Nagai, Kazuhiro; Yokota, Ken-Ichi; Hata, Tomoko; Miyazaki, Yasushi.
Afiliação
  • Chiwata M; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Japan.
  • Itonaga H; Department of Hematology, Nagasaki University Hospital, Japan.
  • Sato S; Department of Hematology, Nagasaki University Hospital, Japan.
  • Hashimoto M; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Japan.
  • Fujioka M; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Japan.
  • Kasai S; Department of Hematology, Nagasaki University Hospital, Japan.
  • Sakamoto H; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Japan.
  • Toriyama E; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Japan.
  • Nakashima J; Department of Hematology, Nagasaki University Hospital, Japan.
  • Kamijo R; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Japan.
  • Kitanosono H; Department of Hematology, Nagasaki University Hospital, Japan.
  • Kobayashi Y; Department of Hematology, Nagasaki University Hospital, Japan.
  • Horai M; Department of Hematology, Japan Community Health care Organization Isahaya General Hospital, Japan.
  • Taguchi M; Department of Hematology, Nagasaki University Hospital, Japan.
  • Matsuo M; Department of Hematology, Sasebo City General Hospital, Japan.
  • Makiyama J; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Japan.
  • Takasaki Y; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Japan.
  • Matsuo E; Department of Hematology, National Hospital Organization Nagasaki Medical Center, Japan.
  • Horio K; Department of Hematology, Nagasaki University Hospital, Japan.
  • Ando K; Department of Hematology, Nagasaki University Hospital, Japan.
  • Sawayama Y; Department of Hematology, Nagasaki University Hospital, Japan.
  • Taguchi J; Department of Hematology, Nagasaki Harbor Medical Center, Japan.
  • Kawaguchi Y; Department of Hematology, Sasebo City General Hospital, Japan.
  • Tsushima H; Department of Hematology, National Hospital Organization Nagasaki Medical Center, Japan.
  • Imanishi D; Department of Hematology, Saint Francis Hospital, Japan.
  • Imaizumi Y; Department of Hematology, National Hospital Organization Nagasaki Medical Center, Japan.
  • Yoshida S; Department of Hematology, Saint Francis Hospital, Japan.
  • Jo T; Department of Hematology, Nagasaki Prefecture Shimabara Hospital, Japan.
  • Nonaka H; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Japan.
  • Moriuchi Y; Department of Hematology, Nagasaki University Hospital, Japan.
  • Nagai K; Department of Hematology, Nagasaki University Hospital, Japan.
  • Yokota KI; Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Japan.
  • Hata T; Department of Internal Medicine, National Hospital Organization Nagasaki Hospital, Japan.
  • Miyazaki Y; Department of Hematology, Nagasaki Harbor Medical Center, Japan.
Intern Med ; 60(14): 2207-2216, 2021 Jul 15.
Article em En | MEDLINE | ID: mdl-33612681
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Leucemia Mielogênica Crônica BCR-ABL Positiva Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Middle aged Idioma: En Revista: Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Leucemia Mielogênica Crônica BCR-ABL Positiva Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Middle aged Idioma: En Revista: Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão